Clinical Trial Update: TITAN (Tumoural Injection of T-VEC and Isolated Limb Perfusion) [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial update evaluating Tumoural Injection of T-VEC with isolated limb perfusion in melanoma and sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Sarcoma

Drugs mentioned

• T-VEC (talimogene laherparepvec)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Melanoma and Sarcoma | Phase 1, Phase 2 | Status: COMPLETED